Listen "Validation of AHA PREVENT in Healthcare Populations | JACC Deep Dive"
Episode Synopsis
In this JACC Deep Dive, JACC Editor in Chief Harlan M. Krumholz, MD, SM, explores a study led by Dr. Pradeep Natarajan that evaluates how well the new AHA PREVENT risk equations predict cardiovascular events across four major U.S. health systems. The study found wide variation in performance—PREVENT was well-calibrated at Penn Medicine but significantly underestimated risk at Mass General Brigham and Vanderbilt, particularly among women and minority groups. Reviewers praised the importance and rigor of the work but raised key questions about model calibration, fairness in outcome comparisons, and whether truly "plug-and-play" risk tools are realistic across diverse healthcare environments.
More episodes of the podcast JACC Deep Dive
Understanding Angina Symptom Trajectories After Invasive vs. Conservative Treatment | JACC Deep Dive
08/09/2025
Tirzepatide in HFpEF and Obesity: Consistent Benefits Regardless of Diabetes Status | JACC Deep Dive
03/09/2025
Master DAPT | JACC Deep Dive
11/08/2025
Revisiting the SUMMIT Trial | JACC Deep Dive
31/07/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.